Active · per the CBE, 17 September 2026

VSMA

BE1020195619

Rechtspersoon Private limited company 1 establishment

VSMA is a specialist medical practice in Schoten. Private Limited, started on 19 February 2025, 1 establishment.

Grimbertlaan 21, 2900 Schoten

Behind the company: Maxim Vanderstappen.

Active for

1 year, 6 months

Financials

Financial year 2025

VSMA from Schoten, company number BE1020195619, closed financial year 2025 with a result of € 54,889 after tax. For that financial year VSMA recorded a gross margin of € 123,902 and equity of € 55,889. The company is profitable. The company holds a healthy buffer. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on August 29, 2026.

What it is worth Healthy

€ 55,889

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 54,889

Profit after tax over the fiscal year.

Cash in the bank

€ 29,613

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Growing

Stays in the company

No dividend for 2025. Retained profit grew to € 54,889.

People and assets in 2025

Full-time equivalents estimate

≈ 1

No payroll staff. One director, so that person most likely runs the business.

Wage cost

€ 25,279

Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 74,272

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 2 years to go

€ 72,197

€ 30,170 is repaid this year. At this pace the long-term loan is gone in ≈ 2 years.

Owed to suppliers

€ 1,323

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 18,871

Taxes, VAT and social contributions still to pay.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

What happened to VSMA?

What happened at VSMA in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

  • New annual accounts for financial year 2025: profit of € 54,889. filed late Source: NBB ↗
  • New establishment in Schoten. KBO
  • Maxim Vanderstappen became a director. NBB
  • Start of the company according to the CBE. KBO

In short

Paid € 14,954 in corporate taxes since 2025.

Management

Maxim Vanderstappen
VSMA

Behind VSMA is Maxim Vanderstappen. Maxim Vanderstappen is also behind TEVADENT.

See the full network in the app

Directors

According to the 2025 annual accounts

Maxim Vanderstappen

Director

Also active at: TEVADENT

since 2025

Establishments

Establishment units

Physical locations of this company

Registered office

Grimbertlaan 21

2900 Schoten

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.

All companies at this address →

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number
1020.195.619
VAT number
BE 1020.195.619
Registered office
Grimbertlaan 21, 2900 Schoten
Names & denominations
VSMA
Enterprise type
Rechtspersoon
Legal form
Private limited company
Legal situation
Normale toestand
Start date
19 February 2025
Peppol
Active · Active since 26 Mar 2025
Activities · NACE

Activiteiten van medisch specialisten

Frequently asked questions

What does VSMA do?
VSMA is a specialist medical practice in Schoten. Private Limited, started on 19 February 2025, 1 establishment.
What is the address of VSMA?
The registered office of VSMA is located at Grimbertlaan 21, 2900 Schoten.
Is VSMA still active?
Yes. According to the CBE (17 September 2026) VSMA is active, legal situation “Normale toestand”, started on 19 February 2025.
Is VSMA registered on Peppol?
Yes, VSMA is registered on the Peppol network with ID 0208:1020195619.
What is the enterprise number of VSMA?
The enterprise number of VSMA is BE1020195619.
When was VSMA founded?
VSMA was founded on 19 February 2025.